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A 2′FY-RNA Motif Defines an Aptamer for Ebolavirus Secreted Protein
Abstract
With properties such as stability to long-term storage and amenability to repetitive use, nucleic acid aptamers
are compatible with many sensing/transducing platforms intended for use in remote locations. Sensors with
these properties are important for quickly identifying ebolavirus outbreaks, which frequently start in locations
that lack sophisticated equipment. Soluble glycoprotein (sGP), an excellent biomarker for ebolaviruses, is
produced from the same gene as the ebolavirus glycoprotein GP1,2 that decorates the surface of the viral
particle and is secreted in abundance into the blood stream even during the early stages of infection. Here, we
report the selection and properties of a 2′fluoro pyrimidine (2′FY)-modified RNA aptamer, 39SGP1A, that
specifically binds sGP. We demonstrate by computational and biochemical analysis that the recognition motif
of 39SGP1A is a novel polypyrimidine-rich sequence. Replacement of -F by -OH in the 2′ position of the
ribose resulted in complete loss of affinity for sGP. The protein motif to which the aptamer binds requires an
intact sGP dimer and binds to an epitope conserved between Ebola virus (EBOV) and Sudan virus (SUDV)
sGP, the most divergent Ebolavirus species. This identifies 39SGP1A as an excellent option for integration on a
sensor platform to detect ebolavirus infections.
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A 2′FY-RNA Motif Defines an 
Aptamer for Ebolavirus Secreted 
Protein
Shambhavi Shubham1,5, Jan Hoinka3, Soma Banerjee2, Emma Swanson1,2, Jacob A. Dillard4, 
Nicholas J. Lennemann4, Teresa M. Przytycka  3, Wendy Maury4 & Marit Nilsen-Hamilton1,2
With properties such as stability to long-term storage and amenability to repetitive use, nucleic 
acid aptamers are compatible with many sensing/transducing platforms intended for use in remote 
locations. Sensors with these properties are important for quickly identifying ebolavirus outbreaks, 
which frequently start in locations that lack sophisticated equipment. Soluble glycoprotein (sGP), an 
excellent biomarker for ebolaviruses, is produced from the same gene as the ebolavirus glycoprotein 
GP1,2 that decorates the surface of the viral particle and is secreted in abundance into the blood 
stream even during the early stages of infection. Here, we report the selection and properties of 
a 2′fluoro pyrimidine (2′FY)-modified RNA aptamer, 39SGP1A, that specifically binds sGP. We 
demonstrate by computational and biochemical analysis that the recognition motif of 39SGP1A is a 
novel polypyrimidine-rich sequence. Replacement of -F by -OH in the 2′ position of the ribose resulted 
in complete loss of affinity for sGP. The protein motif to which the aptamer binds requires an intact sGP 
dimer and binds to an epitope conserved between Ebola virus (EBOV) and Sudan virus (SUDV) sGP, the 
most divergent Ebolavirus species. This identifies 39SGP1A as an excellent option for integration on a 
sensor platform to detect ebolavirus infections.
The species Zaire ebolavirus, in the family of Filoviridae, is a highly virulent enveloped negative strand RNA 
virus that causes hemorrhagic fever with 40–90% fatality. Early detection is the key to controlling outbreaks and 
epidemics such as those that have occurred in the recent past. The GP gene of all Ebolavirus species (Reston, Taï 
Forest, Sudan, Zaire and Bundibugyo) encodes three glycoproteins. The surface exposed trimeric glycoprotein 
(GP1,2) is the minor product, generated as a result of occasional transcriptional slippage. The major translated 
product is soluble glycoprotein (sGP), which is conserved amongst the Ebolavirus species1,2. sGP shares its first 
295 amino acids with GP1,2, but has a unique species-specific 28 amino acid carboxy terminus, and is secreted 
as disulphide-linked, glycosylated homodimers. sGP and GP1,2 share the same 3D structure in the region of 
their sequence identity3. Although, the role of sGP in pathogenesis is not yet established, some antibodies elicited 
during ebolavirus infection cross react with sGP and GP1,2. This observation suggests a role for sGP as a decoy 
for antibodies against GP1,2 on the virus particle4. Consistent with this hypothesis is the observation that sGP 
is secreted in abundance in the early stages of infection and its production is selected for in vivo2,4. Although an 
excellent choice as an ebolavirus biomarker, sGP has so far been overlooked for this purpose.
Aptamers are short nucleic acids (RNA or DNA) that are selected by an in vitro iterative selection protocol 
called Systematic Evolution of Ligands through Exponential Enrichment (SELEX)5–7. They can be chemically 
synthesized at relatively low cost and have been incorporated into a number of diagnostic sensor platforms8. 
For increased stability to nucleases, RNA aptamers are often chemically modified at the 2′ position with fluo-
rine, amino, or methyl groups9,10. Here we describe the application of SELEX combined with Next Generation 
Sequencing (NGS) and analysis by AptaCluster11 and AptaGUI12 to select a 2′FY-RNA aptamer (39SGP1A) with 
high affinity and specificity for sGP. 39SGP1A binds EBOV and SUDV sGP tightly (Kd ~30 nM and 250 nM 
respectively) and does not bind human serum albumin or other proteins present at relatively high concentrations 
in serum. The requirement for structure in the binding of 39SGP1A to sGP is evidenced by the lack of affinity for 
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sGP of the RNA (2′ OH) version of this 2′FY-RNA aptamer. The 2′F modification promotes the C3′ endo confor-
mation in the ribose sugar, stabilizes the 2′FY-RNA structure and increases molecular hydrophobicity13.
In summary, we describe the selection and characterization of an aptamer with a novel 2′FY-RNA binding 
domain consisting of a poly2′F-U loop with GAGC in the stem. This aptamer (39SGP1A) binds tightly to sGP 
from two divergent Ebolavirus species and has potential as a bio sensing element for ebolavirus detection.
Materials and Methods
Nucleic acids. Oligonucleotides used in the study were synthesized by Integrated DNA Technologies 
(IDT; Coralville, IA) or the Iowa State University DNA facility. A DNA single stranded oligonucleotide 
library (487D) was synthesized by IDT with the following sequence: GCCTGTTGTGAGC CTCCTGTCGAA 
(53 N) TTGAGCGTTTATTCTTGTCTCCC. N symbolizes that an equimolar mixture of A, C, G and 
T was used during synthesis of the library. The following primers were used for PCR amplification: 484 
(TAATACGACTCACTATAGGGAGACAAGAATAAACGCTCAA) and 485 (GCCTGTTGTGAG 
CCTCCTGTCGAA) to create dsDNAs that included a 5′T7 polymerase promoter for reverse transcription reac-
tions. Other purchased DNAs were 5196 (AGAAAAATGCAATAAAAAA) and the DNA templates used for pre-
paring 2′FY and 2′OH RNAs for this study (listed in section “Preparation of 2′FY-RNAs”). 39SGP1A 2′FY RNA 
(GGGCGCUCAAUUUUUUAUUGCAUUUUUCUUUGAGCGCCC) was purchased from IDT.
Conversion of ssDNA SELEX library to dsDNA. To generate the starting 2′FY-RNA pool, an extension 
reaction was performed using primer 484 and the starting ssDNA pool. 10 reactions, each of 100 μL and con-
taining 2 μM 487D pool, 3.3 μM 484 primer, 0.5 mM dNTP mix, 0.03 U/μL DNA Taq Polymerase (GenScript) 
in reaction buffer (50 mM KCl, 10 mM Tris-HCl (pH 8.55), 1.5 mM MgCl2, 0.1% TritonX-100) was incubated at 
94 °C for 5 min, 65 °C for 15 min then 72 °C for 99 min using the Multi GENE II PCR minicycler. The generated 
dsDNA was resolved through a 2% agarose gel, purified using a Qiagen PCR purification kit, and quantified using 
a Nanodrop spectrophotometer ND1000 Spectrophotometer (Nanodrop Technologies).
Protein reagents. SUDV sGP (Lot#1610002, Cat# 0570-001) was purchased from IBT Bioservices 
(Rockville, MD). EBOV sGP protein was produced in 15-cm plates of HEK 293 T cells by PEI transfection with 
30 µg of the expression vector. The next day, media was replaced with Opti-MEM low-serum media containing 
1 mM HEPES and 1% non-essential amino acids. Supernatant was collected at 48 and 72 hours following trans-
fection and filtered through a 0.45 µm filter and frozen at −80 °C until purified.
Supernatants were thawed and concentrated by centrifugation using Amicon Ultra-15 Centrifugal Filter Units 
with 10 kDa molecular weight cut off (MWCO). sGP-6xHis present in the concentrated supernatants was bound 
to and eluted from cobalt-bound Dynabeads using the Dynabead His-Tag Isolation & Pulldown Kit (#10103D) 
protocol. Eluted samples were passed through Zeba Spin Desalting Columns (#89882). The desalted material 
was washed 5–10 times with 400 µL of DPBS (Dulbecco’s phosphate buffered saline from Thermo Fisher) in an 
Amicon Ultra-0.5 mL Centrifugal Filter Unit. Final purified samples were diluted to desired concentration in 
DPBS. Purified sGP was analyzed by Coomassie Blue staining and western blotting using anti-GP monoclonal 
antibody, 21D10 (IBT Bioservices).
2′FY-RNA synthesis and purification during SELEX. 2′FY-RNA was prepared by in-vitro transcrip-
tion using a DurascribeTM T7 transcription kit (Epicentre, Madison). About 2 nmoles of dsDNA from the pool 
generated by extension was incubated with 5 mM ATP, 5 mM GTP, 5 mM 2′F-UTP, 5 mM 2′F-CTP, 5 mM DTT, 
5% DMSO, 0.2 U/μL T7 polymerase in a total volume of 2.8 mL and incubated at 37 °C for 4 h. The DNA mixture 
was then digested with 1 MBU DNAse I. The 2′FY-RNA was resolved through a 7 M urea 8% (19:1 acrylamide:bi-
sacrylamide) gel in TBE buffer (89 mM Tris Borate, 2 mM EDTA, pH 9.1) to separate the residual NTPs and 
abortive transcripts. The transcribed RNA was eluted into TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0) by 
incubating for 18 h at 37 °C then ethanol precipitated.
Selection of 2′FY-RNA aptamers against sGP (soluble glycoprotein). Selection of aptamers that 
bind sGP was carried out by SELEX (Systematic Evolution of Ligands by EXponential enrichment). The starting 
2′FY-RNA pool was generated by in-vitro transcription using dsDNA (487D) pool as template. The 2′FY-RNA 
pool (1 × 1015 molecules; 2 nmoles) was incubated with 1 nmole sGP in Buffer A (137 mM NaCl, 2.7 mM KCl, 
10 mM Na2HPO4, 2 mM KH2PO4, 5 mM MgCl2, pH 7.4) at room temperature (RT, which was 23–24 °C) for 1 h 
and the non-binding 2′FY-RNA sequences were removed by passing the mixture through a nitrocellulose mem-
brane on which the protein and bound RNAs were captured. With each subsequent positive selection the ratio of 
2′FY-RNA pool:sGP was increased to increase the stringency of selection. Increased stringency was achieved by 
maintaining a constant amount of 2 nmoles RNA (10 µM) in each round and decreasing the amount of protein to 
incrementally increase the ratio of RNA/protein from 2 to 3, 4, 6.25, 10 and 20, respectively in subsequent positive 
selection rounds. To remove nonspecific membrane binders, negative selections were performed by passing the 
pool through the nitrocellulose membrane in the absence of protein. Reverse transcription and polymerase chain 
reaction amplification (PCR) was used to generate DNA for subsequent selection rounds. Eight rounds of selec-
tion were performed, which included two negative and six positive selections. PCR (15 cycles) was performed 
with the reverse transcribed RNA product from the selected pool, 0.05 U/ul Taq polymerase, 1.5 mM MgCl2, 
0.2 mM of each of the four deoxynucleotide triphosphates, 50 mM KCl, 10 mM Tris-Cl (pH 9.0), 0.01% Triton 
X-100 and 2 µM of each primer (oligonucleotides 484 and 485). The enriched pool from the 8th SELEX round 
was cloned into the TOPO XL PCR cloning plasmid for sequencing, in addition PCR-amplified libraries were 
prepared for NGS using Illumina sequencing primers and appropriate bar coding.
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Bioinformatics Analysis and Data Preprocessing. Raw sequences were demultiplexed and assigned to 
their respective rounds using the preprocessing tool AptaPLEX14 with barcodes ATCACG, TAGCTT, GGCTAC, 
ATGTCA for rounds 1, 4, 6, and 8 respectively. Quality control was performed by allowing a maximum of one 
nucleotide mismatch between the reference and matched barcodes, and a maximum of two mismatches between 
the reference and matched primers (see SELEX library construction in the section “Selection of 2′FY-RNA aptam-
ers against sGP (soluble glycoprotein)”). Any reads not conforming to these standards were excluded from down-
stream analysis. Aptamer families (clusters) were consequently extracted from each round using AptaCLUSTER. 
We performed a total of 10 iterations of locality sensitive hashing, sampling 40% of the indices in the randomized 
regions and allowing no more than 10 nucleotide mismatches between the seed sequence of a cluster to each 
remaining member. The resulting clusters and additional information were visualized and analyzed through the 
graphical user interface AptaGUI.
MEME was run with version 4.12.0 using default parameters whereas secondary structures were predicted 
using Mfold version 2.3 with standard parameters in the RNA mode.
Preparation of 2′FY-RNAs for analysis. 2′FY-RNA was prepared using a Durascribe transcription kit 
(Epicentre Technologies) with PCR-amplified dsDNA, which was prepared from DNA templates containing the 
same sequences as the resulting 2′FY RNAs. Templates used to make each of the 2′FY oligonucleotides used in 
this work are listed in parentheses after the number with the core T7 promoter sequence bolded and italicized. 
The resulting RNA sequences (with T and C in the DNA becoming 2′FU and 2′FC in 2′FY RNAs or U and C in 
2′OH RNAs) are underlined. Single stranded DNAs 4789, 4797 and 5189 were amplified with primer 484 comple-
mentary to the 5′ end, resulting in RNAs with sequences complementary to the underlined sequences.
4789 ( G CC TG TT GT GA GC CT CC TG TC GA AC AG GG TC GG TC AG CG CT AA TT TT AC TT GC TG AA GC TC 
AC AG AC TGCATTACGTTTGAGCGTTTATTCTTGTCTCCC;
4 79 7 ( G CC TG TT GT GA GC CT CC TG TC GA AT CG GC CT AG TT GT TT AA TG TT AA CA AT AG AT TG TT TA A
T CT CG TTGTGTTGCTTTGAGCGTTTATTCTTGTCTCCC);
5011 (TAATACGACTCACTATAGGGCGCTCAATTTTTTATTGAGCGCCC)
5012 (GGGCGCTCAATAAAAAATTGAGCGCCCTATAGTGAGTCGTATTA)
RNA 5015 (GGGCGCUCAAUUUUUUAUUGAGCGCCC) was synthesized from a template that was created 
by annealing oligonucleotides 5011 and 5012.
5 17 9 ( T AA TA CG AC TC AC TA TA GG GA GA CA AG AA TA AA CG CT CA AT CT TT TT AT TT TA CT TT TT GT TG 
TA GA GC GC TT GT TT CT CTGAGTTGTAGCCATTCGACAGGAGGCTCACAACAGGC);
5183 ( T AA TA CG AC TC AC TA TA GG GA GA CA AG AATAAACGCTCAATT T TT TA TT GC AT TT TT CT TT-
GA GC GT CA TT GA TA CC CT GT TT CC TT GA GC AC TTCGACAGGAGGCTCACAACAGGC); 5 18 9 ( A GG AA 
AC AG GG TA TC AA TG AC GC TC AA AG AA AA AT GC AA TA AA AA AT TGAGCGTTTATTCTTGTCTCCC);
5 19 2 ( T AA TA CG AC TC AC TA TA GG GA GA CA TA AA CG CT CA AT TT TT TA TT GC AT TT TT CT TT GA GC G
T CA TT GT GT TTCCTTGAGCACTTCGACAGGAGGCTCACAACAGGC);
5 19 3 ( GCCTGTTGTGAGCCTCCTGTCGAATAGCTCAAGGAAACAGGGTATCATTCTTGTCTCCCTA
TAGTGAGTCGTATTA);
5197 (TAATACGACTCACTATAGGGCGCTCAATTTTTTATTGCATTTTTCTTTGAGCGCCC); 5198 
(GGGCGCTCAAAGAAAAATGCAATAAAAAATTGAGCGCCCTATAGTGAGTCGTATTA)
RNA 5199 (GGGCGCTCAAUUUUUUATTGCAUUUUUCUUUGAGCGCCC) was synthesized from a 
template that was created by annealing oligonucleotides 5197 and 5198.
The transcribed 2′FY-RNA was resolved by electrophoresis through an 8% polyacrylamide–7 M urea gel, and 
eluted from the gel. The 2′FY-RNA was dephosphorylated by incubating for 1 h at 37 °C in 50 mM Tris-Cl pH 
9.3, 1 mM MgCl2, 0.1 mM ZnCl2, 1 mM spermidine, 0.02 U/μL calf intestine phosphatase (Promega, Madison, 
WI) then extracted with phenol-chloroform, and precipitated with ethanol. The 2′FY-RNA was end-labeled by 
incubating with [γ32P] ATP and 1U/ul T4 polynucleotide kinase (New England Biolabs, Ipswich, MA), in 7 mM 
Tris-Cl,1 mM MgCl2, 0.5 mM DTT pH 7.6 at 25 °C. In preparation for the filter capture assay, the 2′FY-RNAs 
(2 nM) were denatured at 95 °C for 5 min. The 100 nt 2′FY RNAs such as 5183 were refolded in Buffer A at room 
temperature (RT) for 30 min. The 2′FY-RNA aptamer, (39SGP1A) was refolded by rapid cooling in ice water for 
5 min then left on the bench for 10 min at RT.
The most stable MFold-predicted structures for all oligonucleotides investigated in this work are shown in 
Fig. S1.
Filter capture assay. Refolded 32P-2′FY-RNAs were incubated at RT for 30 min with varying concentrations 
of sGP (10 nM to 1 μM) then the samples were passed through nitrocellulose membranes (HAWP 02500). The 
filters were immediately washed with 3 mL Buffer A, and the 32P quantified using a liquid scintillation counter 
(Tricarb 4910TR, Perkin Elmer). The data was fit to the formula: F = Fmin + (Fmax*L^n)/(L^n + Kd^n) to deter-
mine the Kd, where Fmax is the maximum bound fraction, L is the ligand concentration, Fmin is the starting 
minimum bound fraction, n is the Hill coefficient and F is the corrected fraction bound. The concentration of sGP 
is reported throughout as the monomer concentration and the Kd is calculated on this basis. Thus, the calculated 
Kd’s reported here should be halved when referring to the sGP dimer.
UV crosslinking and electrophoretic mobility shift assay (EMSA). Refolded 32P-2′FY-RNAs were 
incubated with sGP in Buffer A for 30 min at RT. The mixtures were analyzed for complex formation with sGP 
by resolution through a 6% native polyacrylamide gel run in THE buffer (33 mM Tris, 66 mM HEPES, 0.1 mM 
EDTA-Na, pH 7.5) at 200 V. The 32P was visualized using a phosphorimager.
RNA was in vitro transcribed in the presence of 2′F-UTP and 4-thio-uridine 5′triphosphate (Trilink 
Biotechnologies, San Diego, CA) at a molar ratio of 1:1 and 5′end-labeled with 32P as described previously. Three 
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pmol of RNA was denatured at 95 °C for 5 min followed by immediately cooling on ice for 5 min. The RNA was 
folded in Buffer A for 10 min at RT. To link sGP to the 2′FY-RNA aptamer 5183, 3 pmol 2′FY-RNA was incu-
bated with 15 pmol sGP in 15 μL Buffer A for 20 min at 23 °C for complex formation. This mixture was irradi-
ated for 6 min and 12 min at 4 °C under a UV lamp (365 nm) with the samples placed 3 cm from the lamps. The 
UV-irradiated samples were then treated with proteinase K for 30 min and resolved through a 10% reducing SDS 
PAGE gel to separate the 2′FY-RNA-protein complex, free 2′FY-RNA and free protein. The 32P on the gel was 
visualized using a phosphorimager.
Competition binding assays. Competition binding reactions were performed by incubating 3 μM sGP 
with 9 μM and 18 μM competitor 2′FY-RNA sequences for 30 min at RT in Buffer A. Following the pre-incubation 
period, 32P-labeled 39SGP1A 2′FY-RNA was added to the reaction mix to a final concentration of 150 nM and the 
samples were incubated for 15 min. The 2′FY-RNA-protein complexes were then UV crosslinked at 365 nm for 
15 min at 4 °C. Crosslinked products were analyzed by resolving through a 10% SDS PAGE reducing gel, the gel 
was dried and imaged by Typhoon scanner. Quantification was performed using Image J software.
To establish if the poly2′F-U loop is important for sGP binding, 32P-39SGP1A 2′FY-RNA aptamer was incu-
bated in the presence and absence of a 10-fold excess of unlabeled DNA oligonucleotide 5196 for 20 min. sGP was 
then added and the samples incubated for another 30 min followed by irradiation for 15 min (UV at 365 nm). The 
samples were resolved through a 10% reducing SDS PAGE gel to separate the 2′FY-RNA aptamer-protein complex 
from the free 2′FY-RNA and protein. The 32P on the gel was visualized using a phosphorimager.
Statistics. When two values were subtracted one from the other or divided one by the other, the standard 
deviations were calculated to take into account both errors by calculating the square root of the sum of the squares 
of the two errors. Statistical comparisons were performed by a two-tailed t-test, or a one-way analysis of variance 
(ANOVA) with appropriate post-hoc analysis as indicated. A p value of < 0.05 was considered significant.
Results
Selection of 2′FY-RNAs with high affinities for sGP. 2′FY-RNAs with high affinities for sGP were 
selected from an oligonucleotide pool, consisting of a central 53 nt random sequence region flanked by 25 bases 5′ 
and 3′ constant regions with a starting complexity of ~1015 molecules of 2′FY-RNA. The SELEX protocol followed 
a mathematically defined approach of starting with a relatively high molar ratio of 2:1 (2′FY-RNA: sGP) followed 
by harmonic reductions in the sGP concentration15 to increase the stringency of selections (Fig. 1A). To eliminate 
oligonucleotides with non-specific binding to the nitrocellulose membrane, rounds 4 and 7 were negative selec-
tions, which involved passage through the nitrocellulose filter, but no PCR amplification prior to the subsequent 
rounds 5 and 8 respectively. After 8 rounds of selection, the pools were analyzed by a nitrocellulose filter capture 
assay for evidence of high affinity binding populations. Whereas the initial pool showed a linear increase in 
the fraction bound with no signs of saturation up to 5 μM sGP, the binding curve of the oligonucleotide pool from 
the 8th selection was biphasic with saturation achieved at ~150 nM and ~1 μM respectively suggesting selection of 
high and low affinity 2′FY-RNA binders (Fig. 1B). The filter binding results were corroborated by the results from 
electrophoretic mobility shift assay (EMSA) results using the pools from the 1st and 8th rounds with only the 8th 
round pool demonstrating a mobility shift (Fig. S2). The pools of round 1, 4, 6 and 8 were sequenced resulting in 
the recovery of 254706, 265444, 194055, and 159246 potential aptamer sequences, respectively. The 8th round pool 
was also sub-cloned and sequenced by TOPO-TA cloning, which resulted in 85 clones being analyzed.
Sequencing analysis and identification of conserved sequence motifs. AptaCluster11 and 
AptaGUI12, an open source analysis tool for HT-SELEX data and its graphical user interface, were used for the 
NGS data analysis (Fig. 1C–E). The top 10 sequence clusters identified by AptaCluster from analyzing the NGS 
matched the top 10 sequence clusters obtained from TOPO TA cloning. These clusters are believed to represent 
families of aptamers that are closely related in sequence and derived during PCR due to the low stringency con-
ditions used for transcription. The high-resolution NGS data showed a clear decrease in population diversity 
(the number of unique but possibly multi-copy sequences in a pool) and singletons (single-copy species) with 
increasing rounds of selection, whereas the aptamer families containing enriched sequences (species with increas-
ing copy numbers through subsequent rounds) increased with each round (Fig. 1C). A comparison of the nucle-
otide frequencies at each position in the randomized region between the sequence population of rounds 1 and 
8 also showed that selection had occurred (Fig. 1D,E). 10 oligonucleotides corresponding to the most frequent 
sequences in each of the 10 most abundant clusters were selected and analyzed using MEME16 for the presence of 
possible conserved primary structure motifs. Using this procedure, we identified a conserved sequence motif of a 
stretch of U’s and GAGC in the randomized region of the sequences (Fig. 1F). No other sequence structure motifs 
were found in these or in other enriched clusters examined.
The poly2′F-U/GAGC sequence motif identifies a high affinity aptamer. The affinities of 
2′FY-RNA oligonucleotides 5183, 5177, 5179 and 5182 (Mfold structures in Fig. S3) that contain the poly2′F-U/
GAGC sequence motif were compared with oligonucleotides 4789, 5181 from the top sequence cluster that did 
not contain this motif for their binding affinity to EBOV sGP. Saturation was achieved by 100 nM sGP in titra-
tions against oligonucleotides containing the 2′F-U/GAGC motif, which is consistent with high affinity binding 
(Kds < 100 nM). The percent of the total RNA that bound sGP at saturation was used as an indication of the 
homogeneity of aptamer structure. By this criterion, 2′FY-RNA-5183, with the highest percent binding to sGP, 
was chosen and found to bind with a Kd of 54 nM (Fig. 2A). The amount bound reached saturation and did not 
increase further over a wide range of sGP concentrations (Fig. 2B), which is consistent with the interpretation 
that this oligonucleotide binds tightly to one epitope on sGP and does not bind with low affinity to another loca-
tion on the protein. By contrast, oligonucleotides such as 4789, which did not contain the 2′F-U/GAGC motif, 
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demonstrated much lower affinities (Kd = 0.5–1 μM) for sGP (Fig. 2C). The most stable structures predicted for 
5183 and 4789 by MFold are shown in Fig. 2D,F. The same 5183 sequence in the form of RNA (with 2′OH) did 
not bind sGP (Fig. 2A). Replacement of 2′F-U with U but but retaining the 2′F-C in 5183 also resulted in loss of 
binding activity (Fig. S7). Thus, the 2′F-U modification is essential for 2′FY-RNA-5183 to bind sGP.
EBOV sGP binding by 2′FY-RNA 5183 was confirmed by electrophoretic mobility shift assay (EMSA, Fig. 2E). 
Binding to sGP was tested in the presence and absence of an unrelated RNA aptamer (42UTC1A) that recognizes 
mouse Lcn217. 42UTC1A, in 10-fold molar excess, did not compete for 2′FY-RNA-5183 binding to sGP (Fig. 2E). 
These results are consistent with the hypothesis that the interaction of 2′FY-RNA-5183 with sGP involves a struc-
tural motif on the aptamer rather a basic patch on sGP capable of binding RNAs of many structures based largely 
on electrostatic interactions.
Identification of the RNA epitope that binds sGP. Using AptaGUI to identify the RNA epitope and the 
minimal aptamer sequence for high affinity sGP binding by 2′FY-RNA-5183, we first compared oligonucleotide 
5183 with several other oligonucleotides of the same aptamer family by calculating the base frequency of the 
cluster members at each nucleotide position in relation to 5183. This established the mutation frequencies (arising 
from errors during PCR) through the selections12. From this analysis, we identified the Mfold-predicted18 stem 
loop nearest to the 5′ end, which contains the poly2′F-U/GAGC sequence motif, as the most persistent sequence 
with the lowest mutation rate (Fig. 3A). Based on this analysis, truncations of 5183 (Fig. 3B) were prepared as 
2′FY-RNAs and tested for binding to sGP (Fig. 3C). These results showed that the predicted 3′ stem loop is dis-
pensable for sGP binding (5189) and by itself (5193) does not bind sGP. Removing the central bulge from 5183 
resulted in a better sGP binding (5192), which suggests that the central bulge in 5183 is destabilizing.
Of the oligonucleotides tested, the oligonucleotide with the minimal sequence from 5183 that bound sGP 
with highest affinity (2′FY-RNA oligo 5199) was taken as the sGP aptamer and named 39SGP1A (Fig. 4A). This 
aptamer was further tested for its ability to bind sGP by EMSA by which it was confirmed that the mobility-shifted 
32P-2′FY-5199 RNA contained protein as it was lost after proteinase K treatment (Fig., 4B). Involvement of the 
poly2′F-U loop in sGP binding was tested by hybridizing 5199 with antisense oligonucleotide DNA-5196, which 
is complementary to the loop. The presence of a 10-fold molar excess of DNA-5196 over 39SGP1A resulted in 
50% reduction in the sGP-2′FY-RNA shifted band in EMSA (Fig. 4C). An oligonucleotide containing a truncated 
Figure 1. Next Gen Sequencing Analysis and Consensus Motif Identification (A) A flow diagram showing the 
SELEX protocol for selecting 2′FY-RNA aptamers with high affinity for EBOV sGP. (B) The percent of each 
round of selected 2′FY-RNA that bound EBOV sGP over the concentration ranges shown for the initial pool 
(60 nM 2′FY-RNA) and after the 6th positive selection (22 nM 2′FY-RNA). (C) The frequency of singletons, 
enriched and unique sequences for each SELEX round. (D,E) The frequency of base occurrence in each position 
for the 1st and 6th positive round pools showing evidence of sequence enrichment during selection. (F) A 
conserved sequence motif is identified among the top identified clusters.
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sequence of 39SGP1A (2′FY-RNA-5015), in which the loop consisted of only 6 U’s, had no specificity for sGP 
(Fig. 4D). These results demonstrate that the polyU rich loop is required for specific sGP binding.
We also determined that 39SGP1A binds SUDV sGP, albeit with a 10-fold lower affinity, but still in the nano-
molar range (Fig. 4D). Thus, 39SGP1A is a 2′FY-RNA aptamer that binds EBOV sGP with high affinity and rec-
ognizes an epitope on the protein that is related but is probably not identical to one within SUDV sGP, the most 
genetically distant of the Ebolavirus species.
Specificity of 39SGP1A for sGP over other serum proteins. To establish if 39SGP1A is suitable as 
a sensor for early diagnosis of sGP in patient serum, we tested its affinity for serum proteins. Human serum 
albumin (HSA) is highly abundant in blood, reaching concentrations up to 300 μM, whereas the concentration 
of sGP in serum is likely to be about 2 μM or lower19. Thus, the aptamer affinity for sGP must be more than 
30-fold higher than for HSA to avoid HSA interference in detection of sGP by the aptamer. The original aptamer 
(oligo 5183) bound HSA with an estimated Kd of 400 nM, which is only about 10-fold higher than its Kd for 
sGP (Fig. 5A). However, the minimized aptamer, 39SGP1A, showed no binding to concentrations of HSA up to 
68 μM (Fig. 5A–C). 39SGP1A also did not bind two other highly abundant serum proteins, α2 macroglobulin 
and fibrinogen (Fig. 5C).
Characteristics of the sGP epitopes recognized by the selected 2′FY-RNA oligonucleotides. 
Several 2′FY-RNA oligonucleotide families were identified from the NGS results that are not homologous in 
sequence. Whereas members of the family identified by the poly 2′F-U/GAGC sequence motif bound sGP with 
high affinity, members of other families bound sGP with lower affinity, such as 4789 (Fig. 2C). We tested two of 
these oligonucleotides to establish if they bound to the same sGP epitope as 39SGP1A as demonstrated by their 
abilities to compete for binding of 39SGP1A to sGP (Fig. 6A). Oligonucleotide 5179 (in the same family as 5183), 
which contains the poly2′F-U-GAGC sequence motif (Fig. 1F), binds sGP with a similar high affinity to 5183. 
Figure 2. The Affinities of Selected 2′FY-oligonucleotides for EBOV sGP (A) The concentration dependence 
of EBOV sGP binding to 2 nM 32P-5183, which was in the form of a 2′FY-RNA (2′FY) or a RNA (2′OH). The 
estimated Kd was for the 2′FY-RNA was 54 nM. (B) An extended EBOV sGP titration up to 3 μM against 
2 nM oligonucleotide32 P-5183 to validate saturation of the binding curve. This plot combines the results of 
6 independent experiments, all having at least 3 concentrations higher than 150 nM. To normalize for the 
maximum fraction of RNA bound (as in panel 1 A), which is influenced by the efficiency of RNA folding, the 
data for each experiment was normalized to the maximum bound value prior to compiling and averaging the 
results from all experiments. (C) The concentration dependence of EBOV sGP binding to 20 nM 32P-4789. 
The estimated Kd was 530 nM. (D) The most stable Mfold-predicted secondary structures of oligonucleotides 
4789 and 5183 (all predicted structures are in figures S4 and S5). (E) Electrophoretic mobility shift assay with 
100 nM 32P-oligonucleotide 5183 in Buffer A. no addition; EBOV sGP, 2 μM EBOV sGP; 42UTC1A, 10 μM Lcn2 
aptamer (42UTC1A). The two lanes are from the same gel but with irrelevant lanes removed (see Fig. S5 for the 
uncut image). (F) Sequences of the selected segments of RNAs 4789 and 5183. The sequences of these RNAs 
(excluding the primer sequences) are shown in (D).
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Figure 3. The aptamer binding domain (A) A mutation count chart created in AptaGUI to determine the 
mutation frequency for 5183 at each nucleotide position, (B) The Mfold-predicted secondary structures of 
truncations of 5183. The colored outlines reference the segments of 5183 that have been used to make 5189 
(green) and 5193 (red) and the background highlighting shows the parts of 5183 that were used to construct 
5192. C) Binding of 10 nM 32P-labeled oligonucleotides 5183, 5189, 5192 and 5193 to EBOV sGP at 50 nM (open 
bars) and 500 nM (hatched bars). The colors of the bars are matched with the colors behind the numbers in (B).
Figure 4. Identifying the Binding Epitope for EBOV sGP on the 2′FY RNA Aptamer (A) Mfold-predicted 
2D structures of 5183 and the derived 5199 and 5015 oligonucleotides. The portion of 5183 that was taken as 
5199 (39SGP1A) is highlighted in yellow. Oligonucleotide 5196, which is complementary to 5199, is shown 
in green lettering. (B) UV crosslinking of 200 nM 32P-39SGP1A to 2.5 μM EBOV sGP followed by treatment 
with or without proteinase K then analysis by EMSA. The two lanes are from the same gel but with irrelevant 
lanes removed (see Fig. S6 for an image of the uncut gel). (C) Binding of 0.5 μM 32P-39SGP1A to 10 µM EBOV 
sGP in the presence of 5 μM antisense oligonucleotide 5196, which is complimentary to the loop region of 
oligonucleotide 39SGP1A. **p < 0.05 (ANOVA). (D) Concentration dependence of EBOV and SUDV sGP 
binding to 10 nM 32P-39SGP1A and 10 nM 32P-5015. The estimated Kds from fitting were 27 nM for 39SGP1A 
with EBOV sGP and 240 nM with SUDV sGP, and 4 × 107 for 5015 with EBOV sGP.
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Figure 5. Specificity of Oligonucleotides 5183 and 39SGP1A for EBOV sGP (A) Binding of 2 nM 32P-2′FY-5183 
aptamer and 10 nM 32P-39SGP1A to human serum albumin (HSA). (B) Binding of the 10 nM 32P-39SGP1A 
aptamer to HSA. All values are the average of duplicates with the error bars showing the estimated standard 
deviations (STDs). Where error bars are not seen, the STD is less than the size of the symbol. (C) Binding of 
10 nM 39SGP1A to sGP (240 nM to 960 nM, N = 3, c.v. = 13%) human serum albumin (200 nM to 50 μM, 
N = 6, c.v. = 22%), fibrinogen (250 nM to 4 μM, N = 5, c.v. = 28%) or α2macroglobulin (205 nM to 5 μM, N = 5, 
c.v. = 21%). In each case, a range of protein concentrations was tested for which the N values are shown (an N 
of 1 is the result of a duplicate estimate at one protein concentration). The coefficients of variation (c.v.) for each 
average are consistent with the binding being at a plateau in these concentration ranges. The data used to create 
Fig. 5C is documented in Table S2. ***P < 0.0005 (two tailed Ttest).
Figure 6. Analysis of the Protein Epitope for 39SGP1A (A) γ32P-39SGP1A (0.2 μM) was incubated for 15 min 
at 23 °C with a 100-fold excess of the identified oligonucleotides including the thrombin aptamer (TRA). The 
samples were stabilized by UV crosslinking and resolved by SDS-PAGE. The results from three experiments 
were quantified and compiled. **P < 0.05 (ANOVA). (B) An example of an EMSA from which some of the data 
in (A) was obtained. γ32P-39SGP1A was incubated with 3.8 μM sGP (-sGP-) and with no further additions (−), 
with 10 mM dithiothreitol (DTT) or with 20 μM thrombin aptamer (TRA), 4789 or 4797. After UV crosslinking, 
the samples were resolved by SDS-PAGE.
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Oligonucleotide 4789 (in an aptamer family lacking the poly 2′F-U-GAGC sequence motif), bound sGP with 
lower affinity than 5183 (Fig. 2C). However, when present in 100-fold excess of 39SGP1A, 4789 competed as 
effectively with 32P-39SGP1A for binding to sGP as did 5179 (Fig. 6A). The control thrombin aptamer (TRA) did 
not effectively compete for binding to sGP. Mobility shift assays confirmed that 39SGP1A competed with oligo 
4789 and not with the control thrombin aptamer for binding to sGP (Fig. 6B). These results suggest that sGP has 
a favored nucleic acid binding epitope, which binds aptamers of a variety of affinities, and that the binding affinity 
is determined by the tertiary structure of the 2′FY-RNA.
To test if binding to sGP by 39SGP1A required that the protein be a dimer, the binding reaction was per-
formed in the presence and absence of dithiothreitol. These results showed that the protein epitope is lost when 
the dithiol-linked dimer was separated to form monomers (Fig. 6B) demonstrating that the minimum unit for 
39SGP1A binding is the sGP dimer.
Another 2′FY oligonucleotide selected for sGP binding (4797) did not compete with 39SGP1A, but shifted the 
mobility of the sGP:39SGP1A complex to a higher position on the gel, suggesting that this oligonucleotide binds 
sGP in a different site from that bound by 39SGP1A.
Discussion
In this study, we identified and characterized a 2′FY-RNA aptamer that binds the EBOV sGP dimer with high 
affinity and specificity and also binds SUDV sGP with 10-fold lower affinity. 39SGP1A is the first 2′FY-RNA or 
RNA aptamer reported to be specific for ebolavirus sGP. The choice of sGP as an aptamer target was motivated by 
the fact that it is secreted in abundance in blood early during infection, which makes it an excellent biomarker for 
ebolavirus infection2. sGP is a 82 KDa dimeric glycoprotein secreted by ebolavirus infected cells and is believed to 
be responsible for immune modulation during infection4. An aptamer that binds sGP could be incorporated onto 
a biosensor platform to detect early stages of ebolavirus infection.
The 2′F ribose modification was chosen for aptamer selection as it provides nuclease resistance and has been widely 
used in aptamer selections. After six rounds of positive selection and two rounds of negative selection from a start-
ing pool of ~1015 2′FY modified RNA oligonucleotides our results support the conclusion that the SELEX proto-
col resulted in the selection of two populations of oligonucleotides with high and low affinity for sGP, respectively. 
Some of the selected sequence clusters contained a conserved consensus sequence of poly U and GAGC, for which 
MFold-predicted secondary structures showed the poly U stretch of 18 nt in a loop region followed by GAGC’s in a 
stem. Oligonucleotides containing the polyU/GAGC motif bound sGP with high affinity (Kds = 20–54 nM). The 39 
nucleotide sequence near the 5′ end of the oligonucleotide 5183 containing this motif was identified as the aptamer, 
39SGP1A. Validation of this sequence as the aptamer included demonstrating the capture by UV-crosslinking of 
39SGP1A and sGP in a single complex resolved by EMSA, its high affinity for the selection target, EBOV sGP, and the 
ability of a DNA oligonucleotide (5196), complementary to the polyU loop, to reduce 39SGP1A binding to sGP.
Aptamers from other clusters in the top 10 sequence populations that lacked the polyU/GAGC motif bound 
sGP with lower affinity. High and low affinity oligonucleotides competed for the same site in binding sGP but at 
least one oligonucleotide (4797) appears to bind to a second site on the protein. Thus, there are likely to be at least 
two epitopes on sGP that provide suitable targets for binding by 2′FY RNA aptamers.
The bias for T in the starting pool increased the probability that aptamers with high U content would be 
recovered. We investigated if sGP contained a region with high affinity for poly(U), which is present in some 
proteins20–22, by examining if 5183 RNA (prepared with 2′OH uracil and cytosine) bound sGP. The lack of affinity 
of 5183 RNA for sGP showed that the poly2′F-U is important for aptamer binding. This result and the observed 
differential affinity for EBOV and SUDV sGP is consistent with the hypothesis that the 2′F-U loop folds into a 
structure complementary to a sGP surface epitope.
The presence of 2′F-modified pyrimidines alters RNA structure by promoting the C3′ endo conforma-
tion of the ribose23, which is usually favored in RNA duplexes, increasing their helical stability. In a compari-
son of aptamers selected from libraries of RNA molecules containing 2′ amino- and 2′ fluoro-pyrimidines, the 
2′FY-RNAs were found to have higher affinities than the 2′ NH2 modified aptamers13. The authors speculated that 
the increased affinity of 2′FY modified RNA is due to formation of thermodynamically stable helices and rigid 
structures in 2′FY-RNA compared with the 2′amino modified RNA13. However, X ray crystallography studies 
with 2′F modified and unmodified duplexes demonstrated that the presence of the 2′F modification does not alter 
the overall helical structure of the duplex24. The increased thermodynamic stability of the helices is due to the 
highly electronegative fluorine polarizing the nucleobases, which enhances Watson-Crick pairing. Osmotic stress 
and X ray crystallography studies showed that the presence of 2′fluorine reduced hydration of a duplex, increas-
ing its hydrophobicity24,25. The additional helical stability and hydrophobicity of the 2′FY residues in 39SGP1A 
might promote a more stable structure, stronger intermolecular hydrogen bonding interactions and π-π stacking 
between the available 2′F uracils and hydrophobic amino acid side chains in sGP, thereby increasing aptamer 
affinity for the protein. In our study also, we observed higher retention to the hydrophobic nitrocellulose mem-
branes of oligonucleotides containing poly2′F-U compared with those containing uridine.
39SGP1A binds dimeric, but not monomeric sGP and its binding site does not overlap with the epitopes 
recognized of any of three monoclonal antibodies antibodies (21D10, FVM-09, FVM-04; Fig. S8). The 39SGP1A 
binding site is also conserved between EBOV and SUDV, the most evolutionarily diverse ebolavirus species. 
These results suggest that the protein epitope for 39SGP1A is on a conserved surface on the protein, which is less 
likely to be lost on further evolution of the viral genome.
To be useful for detecting early ebolavirus infections, which would be performed with samples of patient 
blood26 or other body fluids, the 39SGP1A aptamer should not bind other serum proteins and should detect sGP 
in the presence of serum. Albumin, the most abundant serum protein is present in blood at concentrations as high 
as 300 μM. Although the selected oligonucleotide, 5183, from which 39SGP1A was derived, bound to HSA with 
a Kd of 400 nM, 39SGP1A had very low affinity for HSA. Thus, in this instance, truncating the oligonucleotide 
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eliminated the options for 2′FY-RNA structures that could bind HSA. 39SGP1A also did not bind α2 macroglob-
ulin and fibrinogen, two other serum proteins that could contribute to the background noise.
In summary, we report the selection of a 2′FY-RNA aptamer that binds EBOV and SUDV sGP with high affin-
ity and specificity and demonstrate that the 2′F modification and poly2′FU loop is required for binding to sGP. 
This aptamer is an excellent candidate sensor for incorporating into a device for detecting evidence of an Ebola 
virus infection in biological matrices such as blood and serum.
Data availability. All data discussed in this report is available from the authors on request.
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